319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Dettorre, G., Diamantis, N., Loizidou, A., Piccart, M., Chester, J., Jackson, A., Tovazzi, V., Fotia, V., Sita-Lumsden, A., Bower, M., Gaidano, G., Felip, E., Ottaviani, D., Sng, C., Rimassa, L., Santoro, A., Aguilar-Company, J., Seguí, E., Dolly, S., Pinato, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680629/
http://dx.doi.org/10.1016/j.annonc.2020.10.313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680629/
http://dx.doi.org/10.1016/j.annonc.2020.10.313

Ejemplares similares